AAAAAA

   
Results: 1-25 | 26-50 | 51-69
Results: 1-25/69
DIFFERENCE BETWEEN EXPRESSION OF ADHESION MOLECULES ON CD34(-MARROW AND G-CSF-STIMULATED PERIPHERAL-BLOOD() CELLS FROM BONE)
Authors: KROGER N ZELLER W HASSAN HT DIERLAMM J ZANDER AR
Citation: N. Kroger et al., DIFFERENCE BETWEEN EXPRESSION OF ADHESION MOLECULES ON CD34(-MARROW AND G-CSF-STIMULATED PERIPHERAL-BLOOD() CELLS FROM BONE), Stem cells, 16(1), 1998, pp. 49-53
SUCCESSFUL MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS IN HEAVILY PRETREATED MYELOMA PATIENTS WITH G-CSF ALONE
Authors: KROGER N ZELLER W HASSAN HT KRUGER W RENGES H HUMMEL K GUTENSOHN K LOLLIGER C ZANDER AR
Citation: N. Kroger et al., SUCCESSFUL MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS IN HEAVILY PRETREATED MYELOMA PATIENTS WITH G-CSF ALONE, Annals of hematology, 76(6), 1998, pp. 257-262
BUSULFAN, CYCLOPHOSPHAMIDE AND ETOPOSIDE AS HIGH-DOSE CONDITIONING THERAPY IN PATIENTS WITH MALIGNANT-LYMPHOMA AND PRIOR DOSE-LIMITING RADIATION-THERAPY
Authors: KROGER N HOFFKNECHT M HANEL M KRUGER W ZELLER W STOCKSCHLADER M DEWIT M WEH HJ KABISCH H ERTTMANN R ZANDER AR
Citation: N. Kroger et al., BUSULFAN, CYCLOPHOSPHAMIDE AND ETOPOSIDE AS HIGH-DOSE CONDITIONING THERAPY IN PATIENTS WITH MALIGNANT-LYMPHOMA AND PRIOR DOSE-LIMITING RADIATION-THERAPY, Bone marrow transplantation, 21(12), 1998, pp. 1171-1175
SOLUBLE INTERLEUKIN-2 RECEPTOR SERUM LEVELS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION AS A MARKER FOR GVHD
Authors: GRIMM J ZELLER W ZANDER AR
Citation: J. Grimm et al., SOLUBLE INTERLEUKIN-2 RECEPTOR SERUM LEVELS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION AS A MARKER FOR GVHD, Bone marrow transplantation, 21(1), 1998, pp. 29-32
LONG-TERM DISEASE-FREE SURVIVAL OF PATIENTS WITH ADVANCED MANTLE-CELLLYMPHOMA FOLLOWING HIGH-DOSE CHEMOTHERAPY
Authors: KROGER N HOFFKNECHT M DREGER P KRUGER W ZELLER W KRULL A STOCKSCHLADER M BITTNER S WEH HJ ZANDER AR
Citation: N. Kroger et al., LONG-TERM DISEASE-FREE SURVIVAL OF PATIENTS WITH ADVANCED MANTLE-CELLLYMPHOMA FOLLOWING HIGH-DOSE CHEMOTHERAPY, Bone marrow transplantation, 21(1), 1998, pp. 55-57
G-CSF (24-MU-G KG) ALONE VERSUS CHEMOTHERAPY WITH DEXA-BEAM PLUS G-CSF (5-MU-G/KG) IN MOBILIZING PERIPHERAL-BLOOD PROGENITOR CELLS IN PATIENTS WITH MALIGNANT-LYMPHOMA/
Authors: KROGER N ZELLER W FEHSE N HASSAN HT KRUGER W GUTENSHON K LOLLIGER C",MAAS,"KUHNL P ZANDER AR
Citation: N. Kroger et al., G-CSF (24-MU-G KG) ALONE VERSUS CHEMOTHERAPY WITH DEXA-BEAM PLUS G-CSF (5-MU-G/KG) IN MOBILIZING PERIPHERAL-BLOOD PROGENITOR CELLS IN PATIENTS WITH MALIGNANT-LYMPHOMA/, Bone marrow transplantation, 21, 1998, pp. 370-370
SCHEDULE-DEPENDENCY OF 10-MU-G KG G-CSF IN STEADY-STATE MOBILIZATION OF CD34+ PROGENITOR CELLS IN HIGH-RISK BREAST-CANCER PATIENTS (PTS)/
Authors: KROGER N ZELLER W HASSAN T KRUGER W HUMMEL K LOLIGER C BIERMAN B KUHNL P ZANDER AR
Citation: N. Kroger et al., SCHEDULE-DEPENDENCY OF 10-MU-G KG G-CSF IN STEADY-STATE MOBILIZATION OF CD34+ PROGENITOR CELLS IN HIGH-RISK BREAST-CANCER PATIENTS (PTS)/, Bone marrow transplantation, 21, 1998, pp. 810-810
REFINEMENT OF BLOOD-SAMPLING FROM THE SUBLINGUAL VEIN OF RATS
Authors: ZELLER W WEBER H PANOUSSIS B BURGE T BERGMANN R
Citation: W. Zeller et al., REFINEMENT OF BLOOD-SAMPLING FROM THE SUBLINGUAL VEIN OF RATS, Laboratory animals, 32(4), 1998, pp. 369-376
ADVERSE-EFFECTS OF TRIBROMOETHANOL AS USED IN THE PRODUCTION OF TRANSGENIC MICE
Authors: ZELLER W MEIER G BURKI K PANOUSSIS B
Citation: W. Zeller et al., ADVERSE-EFFECTS OF TRIBROMOETHANOL AS USED IN THE PRODUCTION OF TRANSGENIC MICE, Laboratory animals, 32(4), 1998, pp. 407-413
MOBILIZING PERIPHERAL-BLOOD STEM-CELLS WITH HIGH-DOSE G-CSF ALONE IS AS EFFECTIVE AS WITH DEXA-BEAM PLUS G-CSF IN LYMPHOMA PATIENTS
Authors: KROGER N ZELLER W FEHSE N HASSAN HT KRUGER W GUTENSOHN K LOLLIGER C ZANDER AR
Citation: N. Kroger et al., MOBILIZING PERIPHERAL-BLOOD STEM-CELLS WITH HIGH-DOSE G-CSF ALONE IS AS EFFECTIVE AS WITH DEXA-BEAM PLUS G-CSF IN LYMPHOMA PATIENTS, British Journal of Haematology, 102(4), 1998, pp. 1101-1106
SCHEDULE-DEPENDENCY OF GRANULOCYTE-COLONY-STIMULATING FACTOR IN PERIPHERAL-BLOOD PROGENITOR-CELL MOBILIZATION IN BREAST-CANCER PATIENTS
Authors: KROGER N ZELLER W HASSAN HT KRUGER W LOLIGER C ZANDER AR
Citation: N. Kroger et al., SCHEDULE-DEPENDENCY OF GRANULOCYTE-COLONY-STIMULATING FACTOR IN PERIPHERAL-BLOOD PROGENITOR-CELL MOBILIZATION IN BREAST-CANCER PATIENTS, Blood, 91(5), 1998, pp. 1828-1828
HIGH-DOSE CHEMOTHERAPY WITH BUSULFAN, CYCLOPHOSPHAMIDE, AND ETOPOSIDEAS CONDITIONING REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN FIRST COMPLETE REMISSION
Authors: ZANDER AR BERGER C KROGER N STOCKSCHLADER M KRUGER W HORSTMANN M GRIMM J ZELLER W KABISCH H ERTTMANN R SCHONROCK P KUSE R BRAUMANN D ILLIGER HJ FIEDLER W DEWITT M HOSSFELD KD WEH HJ
Citation: Ar. Zander et al., HIGH-DOSE CHEMOTHERAPY WITH BUSULFAN, CYCLOPHOSPHAMIDE, AND ETOPOSIDEAS CONDITIONING REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN FIRST COMPLETE REMISSION, Clinical cancer research, 3(12), 1997, pp. 2671-2675
ALLOGENEIC TRANSPLANTATION WITH CD34(-SELECTED CELLS())
Authors: STOCKSCHLADER M HASSAN HT ZELLER W KRUGER W CLAUSEN J LOLIGER C DIECK AT KROGER N LINK H KABISCH H HOSSFELD DK ZANDER A
Citation: M. Stockschlader et al., ALLOGENEIC TRANSPLANTATION WITH CD34(-SELECTED CELLS()), Leukemia & lymphoma, 25(1-2), 1997, pp. 145-151
FACTORS INFLUENCING HEMATOLOGICAL RECOVERY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION IN LEUKEMIA PATIENTS TREATED WITH METHOTREXATE-CONTAINING GVHD PROPHYLAXIS - A SINGLE-CENTER EXPERIENCE
Authors: HASSAN HT KROG C STOCKSCHLADER M ZELLER W KRUGER W ERTTMANN R ZANDER AR
Citation: Ht. Hassan et al., FACTORS INFLUENCING HEMATOLOGICAL RECOVERY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION IN LEUKEMIA PATIENTS TREATED WITH METHOTREXATE-CONTAINING GVHD PROPHYLAXIS - A SINGLE-CENTER EXPERIENCE, Supportive care in cancer, 5(4), 1997, pp. 299-306
THE ROLE OF SOLUBLE GROWTH-FACTORS IN INDUCING TRANSIENT GROWTH AND CLONAL EXTINCTION OF STROMA CELL-DEPENDENT ERYTHROBLASTIC LEUKEMIA-CELLS
Authors: ITOH K FRIEL J LAKER C ZELLER W JUST U BITTNER S NIBBS RJB HARRISON PR NISHIKAWA SI MORI KJ OSTERTAG W
Citation: K. Itoh et al., THE ROLE OF SOLUBLE GROWTH-FACTORS IN INDUCING TRANSIENT GROWTH AND CLONAL EXTINCTION OF STROMA CELL-DEPENDENT ERYTHROBLASTIC LEUKEMIA-CELLS, Leukemia, 11(10), 1997, pp. 1753-1761
LUMINESCENCE-BASED DETECTION OF THE SPREAD OF FIRE BLIGHT (ERWINIA-AMYLOVORA) IN PLANT-TISSUE AFTER TREATMENT WITH PLANT-EXTRACTS
Authors: HELFERT S ZELLER W
Citation: S. Helfert et W. Zeller, LUMINESCENCE-BASED DETECTION OF THE SPREAD OF FIRE BLIGHT (ERWINIA-AMYLOVORA) IN PLANT-TISSUE AFTER TREATMENT WITH PLANT-EXTRACTS, Zeitschrift fur Pflanzenkrankheiten und Pflanzenschutz, 104(1), 1997, pp. 93-95
CORRELATION OF SOLUBLE-INTERLEUKIN-2 RECEPTOR LEVELS AND ENGRAFTMENT WITH ACUTE GRAFT-VERSUS-HOST DISEASE IN PATIENTS RECEIVING ALLOGENEIC BONE-MARROW TRANSPLANTS
Authors: GRIMM J ZELLER W KROGER N ZANDER AR
Citation: J. Grimm et al., CORRELATION OF SOLUBLE-INTERLEUKIN-2 RECEPTOR LEVELS AND ENGRAFTMENT WITH ACUTE GRAFT-VERSUS-HOST DISEASE IN PATIENTS RECEIVING ALLOGENEIC BONE-MARROW TRANSPLANTS, Experimental hematology, 25(8), 1997, pp. 136-136
STEADY-STATE CD34-CSF IN PATIENTS WITH CHEMOSENSITIVE, PRETREATED MULTIPLE-MYELOMA( CELL MOBILIZATION WITH G)
Authors: KROGER N ZELLER W HASSAN H KRUGER W GRIMM J HUMMEL K HEGEWISCH S ZANDER AR
Citation: N. Kroger et al., STEADY-STATE CD34-CSF IN PATIENTS WITH CHEMOSENSITIVE, PRETREATED MULTIPLE-MYELOMA( CELL MOBILIZATION WITH G), Experimental hematology, 25(8), 1997, pp. 424-424
PHENOTYPE OF LYMPHOCYTE SUBSETS AFTER AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION
Authors: KOEHNE G ZELLER W STOCKSCHLAEDER M ZANDER AR
Citation: G. Koehne et al., PHENOTYPE OF LYMPHOCYTE SUBSETS AFTER AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION, Bone marrow transplantation, 19(2), 1997, pp. 149-156
FACTORS INFLUENCING THE HEMATOLOGICAL RECOVERY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION IN LEUKEMIA PATIENTS TREATED WITH METHOTREXATE-CONTAINING GVHD PROPHYLAXIS - A SINGLE-CENTER EXPERIENCE
Authors: HASSAN HT KROG C STOCKSCHLADER M SCHLEIMER B ZELLER W KRUGER W ERTTMANN R ZANDER AR
Citation: Ht. Hassan et al., FACTORS INFLUENCING THE HEMATOLOGICAL RECOVERY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION IN LEUKEMIA PATIENTS TREATED WITH METHOTREXATE-CONTAINING GVHD PROPHYLAXIS - A SINGLE-CENTER EXPERIENCE, Anticancer research, 17(1B), 1997, pp. 589-599
CHROMOSOMAL ABNORMALITY INV(3)(Q21Q26) ASSOCIATED WITH MULTILINEAGE HEMATOPOIETIC PROGENITOR CELLS IN HEMATOPOIETIC MALIGNANCIES
Authors: SHI GP WEH HJ DUHRSEN U ZELLER W HOSSFELD DK
Citation: Gp. Shi et al., CHROMOSOMAL ABNORMALITY INV(3)(Q21Q26) ASSOCIATED WITH MULTILINEAGE HEMATOPOIETIC PROGENITOR CELLS IN HEMATOPOIETIC MALIGNANCIES, Cancer genetics and cytogenetics, 96(1), 1997, pp. 58-63
LDL RECEPTOR ACTIVITY IN HUMAN-LEUKOCYTE SUBTYPES - REGULATION BY INSULIN
Authors: NAGELE H GEBHARDT A NIENDORF A KROSCHINSKI J ZELLER W
Citation: H. Nagele et al., LDL RECEPTOR ACTIVITY IN HUMAN-LEUKOCYTE SUBTYPES - REGULATION BY INSULIN, Clinical biochemistry, 30(7), 1997, pp. 531-538
ASHAP SALVAGE THERAPY FOR RECURRENT AND REFRACTORY HODGKINS-DISEASE (HD) AND NON-HODGKINS-LYMPHOMA (NHL)
Authors: HANEL M HOFFKNECHT MM PETERS SO FIEDLER F HANEL A KRUGER WH ZELLER W BRAUMANN D ILLIGER HJ METZNER B SCHUBERT JC SCHMITZ N WEH HJ KROGER N ZANDER AR
Citation: M. Hanel et al., ASHAP SALVAGE THERAPY FOR RECURRENT AND REFRACTORY HODGKINS-DISEASE (HD) AND NON-HODGKINS-LYMPHOMA (NHL), Blood, 90(10), 1997, pp. 4559-4559
10 MU-G VERSUS 2 X 5 MU-G G-CSF IN STEADY-STATE MOBILIZATION OF CD34(-RISK BREAST-CANCER PATIENTS (PTS) - HIGHER YIELD BY SPLITTING THE DOSE() PROGENITOR CELLS IN HIGH)
Authors: KROGER N ZELLER W HASSAN T KRUGER W HUMMEL K GOEPFERT C LOLIGER C BIERMANN B ZANDER AR
Citation: N. Kroger et al., 10 MU-G VERSUS 2 X 5 MU-G G-CSF IN STEADY-STATE MOBILIZATION OF CD34(-RISK BREAST-CANCER PATIENTS (PTS) - HIGHER YIELD BY SPLITTING THE DOSE() PROGENITOR CELLS IN HIGH), Blood, 90(10), 1997, pp. 2630-2630
COMPARISON BETWEEN BONE-MARROW AND G-CSF-MOBILIZED PERIPHERAL-BLOOD ALLOGRAFTS UNDERGOING CLINICAL-SCALE CD34(+) CELL SELECTION
Authors: HASSAN HT ZELLER W STOCKSCHLADER M KRUGER W HOFFKNECHT MM ZANDER AR
Citation: Ht. Hassan et al., COMPARISON BETWEEN BONE-MARROW AND G-CSF-MOBILIZED PERIPHERAL-BLOOD ALLOGRAFTS UNDERGOING CLINICAL-SCALE CD34(+) CELL SELECTION, Stem cells, 14(4), 1996, pp. 419-429
Risultati: 1-25 | 26-50 | 51-69